{"url_path":"/sec/wgrx/8-k/2026-05-19/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-024324-index.html","accession_number":"0001493152-26-024324","cik":"0002030763","ticker":"WGRX","issuer_name":"Wellgistics Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-024324-index.html","primary_entity_key":"0002030763","primary_entity_name":"Wellgistics Health, Inc."},"word_count":305,"has_tables":true,"body_markdown":"false\n0002030763\n\n0002030763\n\n2026-05-15\n2026-05-15\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED\nSTATES\nSECURITIES AND EXCHANGE COMMISSION********Washington, D.C. 20549**\n\n** **\n\n**FORM\n8-K**\n\n \n\n**CURRENT\nREPORT\nPURSUANT TO SECTION 13 OR 15(d) OF THE\nSECURITIES EXCHANGE ACT OF 1934**\n\n \n\nDate\nof Report (Date of earliest event reported): **May 15, 2026**\n\n \n\n**WELLGISTICS\nHEALTH, INC.**\n\n(Exact name of registrant as specified in its charter)\n\n \n\n**Delaware**\n \n**001-42530**\n \n**93-3264234**\n\n(State or other jurisdiction\n\nof incorporation)\n\n \n\n(Commission\n\nFile\nNumber)\n\n \n\n(IRS\nEmployer\n\nIdentification\nNo.)\n\n \n\n**3000\nBayport Drive**\n\n**Suite 950**\n\n**Tampa, FL 33607**\n\n(Address of principal executive offices, including zip code)\n\n \n\nRegistrant’s\ntelephone number, including area code: **(844) 203-6092**\n\n** **\n\n**Not\nApplicable**\n\n(Former\nname or former address, if changed since last report)\n\n \n\nCheck\nthe appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under\nany of the following provisions:\n\n \n\n☐\nWritten communications pursuant to Rule 425 under the Securities Act (17\nCFR 230.425)\n\n \n \n\n☐\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17\nCFR 240.14a-12)\n\n \n \n\n☐\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange\nAct (17 CFR 240.14d-2(b))\n\n \n \n\n☐\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange\nAct (17 CFR 240.13e-4(c))\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\n**Title\nof each class**\n \n**Trading\nSymbol(s)**\n \n**Name\nof each exchange on which registered**\n\nCommon\nStock, $0.0001 par value per share\n \nWGRX\n \nThe\nNasdaq Capital Market LLC\n\n \n\nIndicate\nby check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 or Rule 12b-2\nunder the Securities Exchange Act of 1934.\n\n \n\nEmerging\ngrowth company ☒\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}